STERIS (STE) Revenue — Quarter Ended Dec 31, 2025
Revenue for this quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The company's operating cash flow also improved year-over-year, supported by higher earnings according to the filing.
Key takeaway
Quarter ended Dec 31, 2025 · FY2026 Q3
Revenue for this quarter increased compared to both the immediately preceding quarter and the same quarter one year earlier. The company's operating cash flow also improved year-over-year, supported by higher earnings according to the filing.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.5B
Revenue reported for this quarter.
Quarter-over-quarter
+2.5%
Change from the immediately preceding quarter.
Year-over-year
+9.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$5.8B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Mar 31, 2025 | $1.5B | +4.3% |
| Jun 30, 2025 | $1.4B | +8.7% |
| Sep 30, 2025 | $1.5B | +9.9% |
| Dec 31, 2025 | $1.5B | +9.2% |
Revenue performance
Revenue grew relative to the prior quarter and the year-ago period, with the trailing twelve-month figure also trending higher. The filing attributed the operating cash flow increase to elevated earnings.
Quarterly comparison
Compared to the immediately preceding quarter, revenue rose. The year-over-year gain was larger than the sequential change.
What to watch
Monitor whether revenue can sustain its growth trajectory in the coming quarters.